2.35
16.92%
+0.34
Pre-market:
2.35
Allurion Technologies Inc stock is currently priced at $2.35, with a 24-hour trading volume of 146.72K.
It has seen a +16.92% increased in the last 24 hours and a +38.24% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $2.04 pivot point. If it approaches the $2.18 resistance level, significant changes may occur.
Previous Close:
$2.01
Open:
$2.13
24h Volume:
146.72K
Market Cap:
$112.45M
Revenue:
$64.42M
Net Income/Loss:
$-73.78M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-60.50M
1W Performance:
+28.42%
1M Performance:
+38.24%
6M Performance:
-45.48%
1Y Performance:
+0.00%
Allurion Technologies Inc Stock (ALUR) Company Profile
Name
Allurion Technologies Inc
Sector
Industry
Phone
508 647 4000
Address
11 Huron Drive, Natick
Allurion Technologies Inc Stock (ALUR) Latest News
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
Benzinga
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
Benzinga
Dow Jumps Over 100 Points; US Jobless Claims Increase To 221,000
Benzinga
Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Allurion Technologies Inc Stock (ALUR) Financials Data
Allurion Technologies Inc (ALUR) Revenue 2024
ALUR reported a revenue (TTM) of $64.42 million for the quarter ending September 30, 2023.
Allurion Technologies Inc (ALUR) Net Income 2024
ALUR net income (TTM) was -$73.78 million for the quarter ending September 30, 2023.
Allurion Technologies Inc (ALUR) Cash Flow 2024
ALUR recorded a free cash flow (TTM) of -$60.50 million for the quarter ending September 30, 2023.
Allurion Technologies Inc (ALUR) Earnings per Share 2024
ALUR earnings per share (TTM) was -$1.7081 for the quarter ending September 30, 2023.
About Allurion Technologies Inc
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
Cap:
|
Volume (24h):